Ohcanbohtosat - Ivan Nestorov

Population pharmacokinetics and standard uptake value ratio of aducanumab, an amyloid plaque-removing agent, in patients with Alzheimer's disease Dahkki Kumar Kandadi Muralidharan, Xiao Tong, Kenneth G. Kowalski, Raj Rajagovindan, Lin Lin, Samantha Budd Haberlain, Ivan Nestorov

Connect to this object online.

Quantitative systems pharmacology model for Alzheimer's disease to predict the effect of aducanumab on brain amyloid Dahkki Lin Lin, Fei Hua, Cristian Salinas, Carissa Young, Thierry Bussiere, Joshua F. Apgar, John M. Burke, Kumar Kandadi Muralidharan, Rajasimhan Rajagovindan, Ivan Nestorov

Connect to this object online.

A Semi‐Mechanistic Population Pharmacokinetic Model of Nusinersen: An Antisense Oligonucleotide for the Treatment of Spinal Muscular Atrophy Dahkki Konstantinos Biliouris, Puneet Gaitonde, Wei Yin, Daniel A. Norris, Yanfeng Wang, Scott Henry, Robert Fey, Ivan Nestorov, Stephan Schmidt, Mark Rogge, Lawrence J. Lesko, Mirjam N. Trame

Connect to this object online.

An age‐dependent mathematical model of neurofilament trafficking in healthy conditions Dahkki Alessio Paris, Pranami Bora, Silvia Parolo, Michael Monine, Xiao Tong, Satish Eraly, Eric Masson, Toby Ferguson, Alexander McCampbell, Danielle Graham, Enrico Domenici, Ivan Nestorov, Luca Marchetti

Connect to this object online.

A pediatric quantitative systems pharmacology model of neurofilament trafficking in spinal muscular atrophy treated with the antisense oligonucleotide nusinersen Dahkki Alessio Paris, Pranami Bora, Silvia Parolo, Drew MacCannell, Michael Monine, Nick van derMunnik, Xiao Tong, Satish Eraly, Zdenek Berger, Danielle Graham, Toby Ferguson, Enrico Domenici, Ivan Nestorov, Luca Marchetti

Connect to this object online.